Table 1 Baseline characteristics in patients with poor and good collateral
Variables | Poor collateral | Good collateral | P value |
|---|---|---|---|
(n = 122) | (n = 80) | ||
Age (years) | 68.1 ± 10.1 | 65.7 ± 12.0 | 0.146 |
Gender (Female, %) | 37.7 | 25.0 | 0.067 |
DM (%) | 56.6 | 43.8 | 0.085 |
HTN (%) | 82 | 63.8 | 0.005 |
Smoking (%) | 50 | 42.5 | 0.316 |
BMI | 25.0 ± 4.0 | 25.5 ± 3.6 | 0.351 |
eGFR (mL/min/1.73 m2) | 40.7 ± 16.5 | 40.3 ± 16.0 | 0.853 |
Previous events of ACS (%) | 68 | 58.8 | 0.229 |
Laboratory data | Â | Â | Â |
Hemoglobin (g/dl) | 12.2 ± 2.3 | 12.2 ± 2.6 | 1.000 |
Cholesterol (mg/dl) | 198.5 ± 41.8 | 212.4 ± 67.8 | 0.104 |
Triglyceride (mg/dl) | 187.7 ± 142.3 | 168.6 ± 138.1 | 0.360 |
Uric acid (mg/dl) | 7.1 ± 2.2 | 6.9 ± 2.0 | 0.713 |
Medication | Â | Â | Â |
Anti-platelet (%) | 43.4 | 51.3 | 0.314 |
ACEI (%) | 19.8 | 21.3 % | 0.855 |
ARB (%) | 21.6 | 24.0 | 0.725 |
Beta blocker (%) | 30.8 | 34.7 | 0.636 |
Nitrate (%) | 24.8 | 30.7 | 0.407 |
CCB (%) | 25 | 17.3 | 0.283 |
Diuretic (%) | 21.6 | 24.0 | 0.725 |
Statin (%) | 18.6 | 27.6 | 0.159 |